BIMI International Medical Inc. (BIMI)

Market Cap	5.77M
Revenue (ttm)	19.14M
Net Income (ttm)	-40.27M
Shares Out	3.84M
EPS (ttm)	-59.70
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,296
Open	1.50
Previous Close	1.42
Day's Range	1.45 - 1.52
52-Week Range	1.07 - 21.50
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 2, 2023

About BIMI

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the ...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• CEO: Tiewei Song
• Employees: 524
• Stock Exchange: NASDAQ
• Ticker Symbol: BIMI

Financial Performance

In 2021, BIMI's revenue was $27.08 million, an increase of 110.82% compared to the previous year's $12.84 million. Losses were -$34.99 million, 1651.9% more than in 2020.